Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 20.01.2025 2 Ann Neurol 2 Diabet Med 2 Diabetes 3 Diabetes Res Clin Pract 3 Intern Med 2 J Autoimmun 2 J Neuroimmunol 13 J Neurol 2 Lancet 1 Mult Scler 1 Nat Rev Neurol 1 Neurol Clin Pract 5 Neurology 1 PLoS Genet 3 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. HASHEMI E, Srivastava IN, Aguirre A, Yoseph ET, et al
   A Novel Mouse Model for Cerebral Inflammatory Demyelination in X-Linked Adrenoleukodystrophy: Insights into Pathogenesis and Potential Therapeutic Targets.
   Ann Neurol. 2025;97:296-312.
   PubMed         Abstract available
   
   
2. MARGONI M, Storelli L, Pagani E, Preziosa P, et al
   Subventricular Zone Microstructure in Pediatric-Onset Multiple Sclerosis.
   Ann Neurol. 2025 Jan 18. doi: 10.1002/ana.27180.
   PubMed         Abstract available
   
   

   
   Diabet Med

3. BANERJEE A, Brackenridge A
   Managing diabetic chronic kidney disease in pregnancy: Current clinical practice and uncertainties.
   Diabet Med. 2024 Nov 21:e15460. doi: 10.1111/dme.15460.
   PubMed         Abstract available
   
   
4. JANSSON SIGFRIDS F, Lithovius R, Groop PH, Thorn LM, et al
   Lessons learned from the FinnDiane Study: Epidemiology and metabolic risk factors for diabetic kidney disease in type 1 diabetes.
   Diabet Med. 2024 Sep 5:e15431. doi: 10.1111/dme.15431.
   PubMed         Abstract available
   
   

   
   Diabetes

5. JIA X, Wenzlau JM, Zhang C, Dong F, et al
   Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
   Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571.
   PubMed         Abstract available
   
   
6. HOHENSTEIN AC, Gallegos J, Dang M, Groegler J, et al
   Novel T Cell reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Subjects.
   Diabetes. 2025 Jan 16:db240611. doi: 10.2337/db24-0611.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

7. DRISCOLL KA, Geno Rasmussen CR, O'Donnell H, Trojanowski P, et al
   Men with type 1 diabetes had a more than 7-fold odds of elevated depressive symptoms compared to men without diabetes.
   Diabetes Res Clin Pract. 2025;219:111947.
   PubMed         Abstract available
   
   
8. FRANCESCHI R, Pertile R, Marigliano M, Mozzillo E, et al
   Factors influencing the acceptability of automated insulin delivery systems in youths with type 1 diabetes and their parents.
   Diabetes Res Clin Pract. 2025;219:111962.
   PubMed         Abstract available
   
   
9. GAMARRA E, Trimboli P, Careddu G, Fazi A, et al
   Performance of a safety protocol for scuba diving in people with type 1 diabetes: 20 years of "Diabete Sommerso(R)" experience.
   Diabetes Res Clin Pract. 2025;219:111945.
   PubMed         Abstract available
   
   

   
   Intern Med

10. YAMAGUCHI Y, Sawaya R, Shichinohe N, Tanei ZI, et al
    Acute Hemorrhagic Leukoencephalitis with Concurrent Retinal Vasculitis in an Elderly Japanese Patient.
    Intern Med. 2025;64:301-306.
    PubMed         Abstract available
    
    
11. NAKAMURA T, Uryu H, Kawashima R, Ishiguro M, et al
    Primary Adrenal Insufficiency Triggered by Cytomegalovirus Infection after Obinutuzumab Plus Bendamustine Therapy for Follicular Lymphoma.
    Intern Med. 2025;64:273-279.
    PubMed         Abstract available
    
    
12. ASANO Y, Matsumoto Y, Kubota N, Terajima Y, et al
    Dyspnea with Hemidiaphragm Elevation in a Patient with Giant Cell Arteritis: A Case Report.
    Intern Med. 2025 Jan 15. doi: 10.2169/internalmedicine.4055.
    PubMed         Abstract available
    
    

    
    J Autoimmun

13. LU Y, Man XY
    Diversity and function of regulatory T cells in health and autoimmune diseases.
    J Autoimmun. 2025;151:103357.
    PubMed         Abstract available
    
    
14. AROWOSEGBE A, Guo Z, Vanderleeden E, Derr AG, et al
    Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats.
    J Autoimmun. 2025;151:103358.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

15. GULEC B, Everest E, Uygunoglu U
    Letter to the Editor Regarding "Spinocerebellar ataxia masquerading as multiple sclerosis, a case report".
    J Neuroimmunol. 2025;399:578523.
    PubMed        
    
    
16. FALSO S, Zara P, Marini S, Puci M, et al
    Seasonal variation in myasthenia gravis incidence.
    J Neuroimmunol. 2025;399:578524.
    PubMed         Abstract available
    
    

    
    J Neurol

17. MAIWORM M, Koerbel K, Anschutz V, Jakob J, et al
    BDNF levels in serum and CSF are associated with clinicoradiological characteristics of aggressive disease in MS patients.
    J Neurol. 2025;272:147.
    PubMed         Abstract available
    
    
18. MAR S, Valeriani M, Steinborn B, Schreiner T, et al
    Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study.
    J Neurol. 2025;272:137.
    PubMed         Abstract available
    
    
19. BALSHI A, Dempsey J, Kumbar S, Leunberger G, et al
    Marriage is associated with decreased lesion volumes and less brain atrophy in people with multiple sclerosis.
    J Neurol. 2025;272:151.
    PubMed         Abstract available
    
    
20. PREZIOSA P, Pagani E, Meani A, Margoni M, et al
    Soma and neurite density abnormalities of paramagnetic rim lesions and core-sign lesions in multiple sclerosis.
    J Neurol. 2025;272:145.
    PubMed         Abstract available
    
    
21. PLESS S, Woelfle T, Lorscheider J, Wiencierz A, et al
    CoGames: Development of an adaptive smartphone-based and gamified monitoring tool for cognitive function in Multiple Sclerosis.
    J Neurol. 2025;272:119.
    PubMed         Abstract available
    
    
22. ZANGHI A, Greco A, Giancipoli E, Tumani H, et al
    Unraveling the inflammation-degeneration tangle in early MS: preliminary insights from ferritin, neurogranin, TREM2, and retinal ganglion cell layer.
    J Neurol. 2025;272:109.
    PubMed         Abstract available
    
    
23. FOCKE JK, Brokbals M, Becker J, Veltkamp R, et al
    Cerebral vasculitis related to neurosarcoidosis: a case series and systematic literature review.
    J Neurol. 2025;272:135.
    PubMed         Abstract available
    
    
24. MIRMOSAYYEB O, Weinstock-Guttman B, Zivadinov R, Jakimovski D, et al
    Anatomy-driven segmentation of parafoveal optical coherence tomography (OCT) measures may improve associations with clinical outcomes in multiple sclerosis.
    J Neurol. 2025;272:141.
    PubMed         Abstract available
    
    
25. LAGEMAN SB, Jolly A, Sahi N, Prados F, et al
    Explaining cognitive function in multiple sclerosis through networks of grey and white matter features: a joint independent component analysis.
    J Neurol. 2025;272:142.
    PubMed         Abstract available
    
    
26. PIHL-JENSEN G, Frederiksen JL
    The value of magnetic resonance imaging of the optic nerve for the diagnosis of multiple sclerosis in patients with optic neuritis.
    J Neurol. 2025;272:131.
    PubMed         Abstract available
    
    
27. INOJOSA H, Schriefer D, Ness NH, Dillenseger A, et al
    Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation study.
    J Neurol. 2025;272:153.
    PubMed         Abstract available
    
    
28. BOAVENTURA M, Fragoso DC, Avolio I, Pereira SA, et al
    Brain tissue integrity in neuromyelitis optica spectrum disorder through T1-w/T2-w ratio, MTR and DTI.
    J Neurol. 2025;272:157.
    PubMed         Abstract available
    
    
29. LIU M, Ren H, Yao D, Yao M, et al
    Autoimmune cerebellar ataxia associated with anti-SEZ6L2 antibody: report of three cases.
    J Neurol. 2025;272:127.
    PubMed        
    
    

    
    Lancet

30. BENHADOU F, Cogan E
    Targeting IFNbeta in dermatomyositis.
    Lancet. 2025;405:99-101.
    PubMed        
    
    
31. FIORENTINO D, Mangold AR, Werth VP, Christopher-Stine L, et al
    Efficacy, safety, and target engagement of dazukibart, an IFNbeta specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
    Lancet. 2025;405:137-146.
    PubMed         Abstract available
    
    

    
    Mult Scler

32. YILMAZER C, D'haeseleer M, Soler B, Van Wijmeersch B, et al
    Assessing pain in multiple sclerosis: Test-retest reliability of patient-reported outcome measures and accuracy of screening tools.
    Mult Scler. 2025 Jan 16:13524585241310139. doi: 10.1177/13524585241310139.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

33. MURARO PA, Mariottini A, Greco R, Burman J, et al
    Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis and neuromyelitis optica spectrum disorder - recommendations from ECTRIMS and the EBMT.
    Nat Rev Neurol. 2025 Jan 15. doi: 10.1038/s41582-024-01050.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

34. HOUTCHENS MK, Manieri MC, Mahlanza TD, Pol-Patil J, et al
    A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
    Neurol Clin Pract. 2025;15:e200425.
    PubMed         Abstract available
    
    

    
    Neurology

35. CARVAJAL R, Guananga-Alvarez D, Tur C, Esperalba J, et al
    Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS.
    Neurology. 2025;104:e210281.
    PubMed         Abstract available
    
    
36. AMEZCUA L, Cardenas-Iniguez C, Orlando C, Martinez A, et al
    Person-Centered Social Determinants and Neighborhood-Level Deprivation Associated With Disability in Hispanic People With Multiple Sclerosis.
    Neurology. 2025;104:e213332.
    PubMed         Abstract available
    
    
37. 
    Randomized Phase 2 Study of FcRn Antagonist Efgartigimod in Generalized Myasthenia Gravis.
    Neurology. 2025;104:e210299.
    PubMed        
    
    
38. 
    Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test.
    Neurology. 2025;104:e210298.
    PubMed        
    
    
39. CRUCIANI A, Toosy AT
    Progression Independent of Relapse Activity in Multiple Sclerosis: More, or Less, Than Meets the Eye?
    Neurology. 2025;104:e210296.
    PubMed        
    
    

    
    PLoS Genet

40. MORA-BITRIA L, Debebe BJ, Miners KL, Ladell K, et al
    Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes.
    PLoS Genet. 2024;20:e1011456.
    PubMed         Abstract available
    
    

    
    PLoS One

41. XU Y, Wang Z, Jia T, Liang S, et al
    Exploring potential drug targets for SLE through Mendelian randomization and network pharmacology.
    PLoS One. 2025;20:e0316481.
    PubMed         Abstract available
    
    
42. KATZ A, Shulkin A, Fortier MA, Yardley JE, et al
    Strategies to reduce hyperglycemia-related anxiety in elite athletes with type 1 diabetes: A qualitative analysis.
    PLoS One. 2025;20:e0313051.
    PubMed         Abstract available
    
    
43. RAO GA, Shoaibi A, Makadia R, Hardin J, et al
    CohortDiagnostics: Phenotype evaluation across a network of observational data sources using population-level characterization.
    PLoS One. 2025;20:e0310634.
    PubMed         Abstract available
    
    

    
    Thyroid

44. CHOU YT, Lai CC, Li CY, Shen WC, et al
    Statin Use and the Risk of Graves' Orbitopathy: A Nationwide Population-Based Cohort Study.
    Thyroid. 2025 Jan 13. doi: 10.1089/thy.2024.0536.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.